Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study

BACKGROUND: The WHO Model List of Essential Medicines for Children (EMLc) covers medicines for globally high-burden diseases. Regulatory approval in high-income countries ensures evidence and dosage form but usually focuses on diseases common in those countries and not in low- and middle-income coun...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimazawa, Rumiko, Ikeda, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217454/
https://www.ncbi.nlm.nih.gov/pubmed/28070339
http://dx.doi.org/10.1186/s40545-016-0094-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217454/
https://www.ncbi.nlm.nih.gov/pubmed/28070339
http://dx.doi.org/10.1186/s40545-016-0094-2

Ejemplares similares